Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Daiichi Sankyo Inc. |
---|---|
Information provided by: | Daiichi Sankyo Inc. |
ClinicalTrials.gov Identifier: | NCT00412932 |
This 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: Olmesartan medoxomil Drug: Olmesartan medoxomil/hydrochlorothiazide |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension |
Estimated Enrollment: | 200 |
Study Start Date: | December 2006 |
Estimated Study Completion Date: | April 2008 |
Estimated Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Daiichi Sankyo ( William Waverczak ) |
Study ID Numbers: | 866-450 |
Study First Received: | December 14, 2006 |
Last Updated: | March 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00412932 |
Health Authority: | United States: Food and Drug Administration |
Hypertension Angiotensin Receptor Blocker Calcium Channel Blocker |
Angiotensin Converting Enzyme Inhibitor Hydrochlorothiazide Stage I and II Hypertension |
Calcium, Dietary Vascular Diseases Olmesartan medoxomil |
Angiotensin II Hydrochlorothiazide Hypertension |
Angiotensin II Type 1 Receptor Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Natriuretic Agents Therapeutic Uses Sodium Chloride Symporter Inhibitors |
Physiological Effects of Drugs Diuretics Cardiovascular Diseases Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |